CLEVELAND, June 14 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced another benefit of the DATATRAK ONE(TM) solution - the expansion of the Company's industry standards library.
With the continuing development of the DATATRAK eClinical(TM) product, the Company has increased its utilization of industry standards in its processes and products. The recent deployment of the Safety Export (XML export to E2B) further enhanced the standards in DATATRAK's growing library, which already includes the HL7 import of ECGs and CDISC SDTM data export. As part of its continuing commitment to reducing clients' trial costs, DATATRAK has designed a study library using the CDISC CDASH field naming. Studies can be designed more efficiently using the CDASH library, and variable names are automatically exported to the CDISC Study Data Tabulation Model (SDTM). In addition to domains explicitly defined by CDISC, our library includes over twenty-five standard industry questionnaires, common lab tests and other procedures.
"Helping our clients understand and implement industry standards is an important focus within the services component of DATATRAK ONE(TM). Not only does DATATRAK's standards library lower trial costs, it decreases deployment timelines," said Laurence Birch, DATATRAK's Chairman of the Board. "Seamless data flow is inherent within our unified platform; however when interfacing with clients' third party systems or other data stores, standards are mandatory in order to maximize trial efficiencies."
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONE(TM), the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical(TM) software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net/.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on May 12, 2010 announcing its results for the three month period ending March 31, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
DATATRAK International, Inc.
CONTACT: Varnesh Sritharan, Vice President of Legal Affairs, DATATRAK
International, Inc., +1-440-443-0082 x 143
Web Site: http://www.datatrak.net/
